PTC Therapeutics
PTCT
#2822
Rank
โ‚น581.89 B
Marketcap
โ‚น7,015
Share price
3.94%
Change (1 day)
69.05%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2025 (TTM): โ‚น58.84 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are โ‚น1.73 Billion. , an increase over its 2024 earnings that were of -โ‚น34.5 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น66.17 B-291.84%
2024 -โ‚น34.5 Billion-47.84%
2023 -โ‚น66.13 Billion18.49%
2022 -โ‚น55.81 Billion13.34%
2021 -โ‚น49.24 Billion28.64%
2020 -โ‚น38.28 Billion67.94%
2019 -โ‚น22.8 Billion87.28%
2018 -โ‚น12.17 Billion64.95%
2017 -โ‚น7.38 Billion-45.13%
2016 -โ‚น13.45 Billion-16.72%
2015 -โ‚น16.15 Billion72.64%
2014 -โ‚น9.36 Billion90.89%
2013 -โ‚น4.9 Billion96.58%
2012 -โ‚น2.5 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.499 T 2,165.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น480.82 B 626.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น13.11 Billion-119.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น66.71 Billion-200.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น15.2 Billion-122.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น65.04 Billion-198.28%๐Ÿ‡บ๐Ÿ‡ธ USA